Langabeer S. The JAK2 V617F mutation in lung cancer: caveat emptor. Exp. oncol. [Internet]. 2018 Dec. 22 [cited 2026 May 4];40(4):343-4. Available from: https://exp-oncology.com.ua/index.php/Exp/article/view/2018-4-1